Avid Bioservices reports mixed Q4 results; initiates FY24 outlook
2024-07-03
Avid Bioservices press release (NASDAQ:CDMO): Q4 GAAP EPS of -$1.94 misses by $1.90. Revenue of $42.98M (+8.0% Y/Y) beats by $0.84M. As of April 30, 2024, the company’s backlog was $193 million, consistent with a backlog of $191 million at the end of the same quarter last year. The companyContinue Reading
